<html>
<head>PUBMED IDs for CDK4I</head>
<body bgcolor='#C5F0F2'><h1>CDK4I</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8012957/'>Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.</a> July 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7923152/'>Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.</a> October 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7919362/'>Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias.</a> October 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7919360/'>p53 in hematologic malignancies.</a> October 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7919359/'>Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.</a> October 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7802046/'>Ectrodactyly and 7q22.1.</a>  10  <br><a href='https://pubmed.ncbi.nlm.nih.gov/8001221/'>MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma.</a> December 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7954450/'>Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.</a> December 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7700630/'>CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.</a> March 16  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7775255/'>Frequent loss of the cyclin-dependent kinase-4 inhibitor gene in human gliomas.</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7775254/'>Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas.</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7775088/'>[Cell differentiation and local regulatory systems].</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7775087/'>[Molecular mechanisms of hematopoietic stem cell differentiation].</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7775080/'>[Immunology and genetics of rheumatoid arthritis].</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7775079/'>[Molecular regulatory processes in glomerular cells of the kidney].</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7718873/'>Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia.</a> April 15  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8668350/'>Deletions of the p16 gene in pediatric leukemia and corresponding cell lines.</a> May 16  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8887073/'>Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.</a> July 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9052747/'>Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours.</a> March 4  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9333020/'>p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx.</a> October 23  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9433042/'>Malignant melanoma of the uterine cervix: a case report.</a> January 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10328220/'>Disregulation of p16MTS1/CDK4I protein and mRNA expression is associated with gene alterations in squamous-cell carcinoma of the larynx.</a> May 18  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10921309/'>[Familial malignant melanoma].</a> August 2  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12148857/'>Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.</a> August 1  2002<br></body></html>
